Bio-Rad Laboratories, Inc, a leading provider of life science research and clinical diagnostics solutions, has unveiled the ...

We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are ...

HERCULES, Calif. - Bio-Rad Laboratories, Inc. (NYSE:BIO) reported fourth-quarter results that fell short of analyst expectations, sending shares down 4% in after-hours trading Thursday.

Equities researchers at Zacks Research reduced their Q1 2025 EPS estimates for shares of Bio-Rad Laboratories in a research ...

HERCULES, Calif. — 10 March Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics ...

Bio-Rad Laboratories, a Bay Area biotech giant best known for its diagnostic and research products, is laying off 5% of its staff — including more than 100 workers from its headquarters in Hercules.

Key Insights Significantly high institutional ownership implies Bio-Rad Laboratories' stock price is sensitive to ...

Bio-Rad Laboratories had a negative net margin of 30.18% and a positive return on equity of 3.74%. Equities analysts forecast that Bio-Rad Laboratories will post 10.33 EPS for the current fiscal year.

Explore how BIO's revenue and expenses shape its earnings. Looking ahead, revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Life ...

Bio-Rad Laboratories, Inc has introduced Vericheck ddPCR™ Empty-Full Capsid Kits for adeno-associated virus (AAV) serotypes 2 ...

The principal job function of the Technical Service Staff (Field Service Engineer) is to provide after-sales field technical ...